Recent Updates
Recently added Catalysts
ACB Positive Sentiment Score: 70/100

Aurora Cannabis to Host Second Quarter Fiscal Year 2024 Investor Conference Call NASDAQ | TSX

Key Takeaway: Aurora Cannabis Inc. has announced a conference call scheduled for November 9, 2023, to discuss its financial results for the second quarter of fiscal year 2024. The call will occur at 5:00 p.m. Eastern Time, following the release of the results after market close. This initiative demonstrates Aurora's commitment to keeping investors informed about its performance and future direction.

Market Sentiment Analysis

POSITIVE FACTORS

  • Aurora Cannabis is expanding its transparency with an upcoming investor conference call.
  • The scheduled financial results report indicates the company is proactive in informing stakeholders.
  • The leadership team, including the CEO and CFO, will engage directly with investors.

Full Press Release Details

to Host Second Quarter Fiscal Year 2024 Investor Conference Call
26, 2023 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company
opening the world to cannabis, announced today that it has scheduled a conference call to discuss the results for its second quarter
fiscal year 2024 on Thursday, November 9, 2023 at 5:00 p.m. Eastern Time | 3:00 p.m. Mountain Time. The Company will report its financial
results for the second quarter fiscal year 2024 after the close of markets that same day.
DATE: Thursday, November 9, 2023
TIME: 5:00 p.m. Eastern Time | 3:00 p.m. Mountain Time
WEBCAST: Click Here
Miguel Martin, Chief Executive Officer, and Glen Ibbott, Chief Financial Officer, will host the conference
call and question and answer period. This weblink has also been posted to the Company's "Investor Info" link at https://www.auroramj.com/investors/ under
Aurora is opening the
world to cannabis, serving both the medical and consumer markets. Headquartered in Edmonton, Alberta, Aurora is a pioneer in global cannabis,
dedicated to helping people improve their lives. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily
Special, Tasty's, Whistler, Being and Greybeard. Medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana
Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Aurora also has a controlling interest in Bevo Farms Ltd., North
America's leading supplier of propagated agricultural plants. Driven by science and innovation, and with a focus on high-quality cannabis
products, Aurora's brands continue to break through as industry leaders in the medical, performance, wellness and adult recreational
Aurora's common shares
trade on the NASDAQ and TSX under the symbol "ACB".
Forward Looking Statements
This news release includes
statements containing certain "forward-looking information" within the meaning of applicable securities law ("forward-looking
statements"). Forward-looking statements are frequently characterized by words such as "plan", "continue", "expect",
"project", "intend", "believe", "anticipate", "estimate", "may", "will",
"potential", "proposed" and other similar words, or statements that certain events or conditions "may"
or "will" occur. Forward-looking statements made in this news release include statements regarding timing of the release of
the Company's financial statements for second quarter ended September 30, 2023 and scheduling of the conference call to discuss
These forward-looking
statements are only predictions. Forward looking information or statements contained in this news release have been developed based on
assumptions management considers to be reasonable. Material factors or assumptions involved in developing forward-looking statements
include, without limitation, publicly available information from governmental sources as well as from market research and industry analysis
and on assumptions based on data and knowledge of this industry which the Company believes to be reasonable. Forward-looking statements
are subject to a variety of risks, uncertainties and other factors that management believes to be relevant and reasonable in the circumstances
could cause actual events, results, level of activity, performance, prospects, opportunities or achievements to differ materially from
those projected in the forward-looking statements. These risks include, but are not limited to, the ability to retain key personnel,
the ability to continue investing in infrastructure to support growth, the ability to obtain financing on acceptable terms, the continued
quality of our products, customer experience and retention, the development of third party government and nongovernment consumer sales
channels, management's estimates of consumer demand in Canada and in jurisdictions where the Company exports, expectations of future
results and expenses, the risk of successful integration of acquired business and operations, management's estimation that SG&A will
grow only in proportion of revenue growth, the ability to expand and maintain distribution capabilities, the impact of competition, the
general impact of financial market conditions, the yield from cannabis growing operations, product demand, changes in prices of required
commodities, competition, and the possibility for changes in laws, rules, and regulations in the industry, epidemics, pandemics or other
public health crises, including the current outbreak of COVID-19, and other risks, uncertainties and factors set out under the heading
"Risk Factors" in the Company's annual information form dated June 14, 2023 (the "AIF") and filed with Canadian securities
regulators available on the Company's issuer profile on SEDAR at www.sedarplus.com and filed with and available on the SEC's website
at www.sec.gov. The Company cautions that the list of risks, uncertainties and other factors described in the AIF is not exhaustive and
other factors could also adversely affect its results. Readers are urged to consider the risks, uncertainties and assumptions carefully
in evaluating the forward-looking statements and are cautioned not to place undue reliance on such information. The Company is under
no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a
result of new information, future events or otherwise, except as expressly required by applicable securities law.
View original content
SOURCE Aurora Cannabis
View original content
For further information: For Media:
Michelle Lefler, VP, Communications & PR, media@auroramj.com; For Investors: ICR, Inc., Investor Relations, aurora@icrinc.com
CNW 17:30e 26-OCT-23

Frequently Asked Questions

When is Aurora's second quarter fiscal call scheduled?

The call is set for November 9, 2023, at 5:00 p.m. Eastern Time.

Who will host the investor conference call?

The call will be hosted by CEO Miguel Martin and CFO Glen Ibbott.

What time will the financial results be released?

Aurora will release its financial results after market close on the same day.

How can investors join the conference call?

Investors can join through the provided webcast link on Aurora’s website.

What brands does Aurora Cannabis offer?

Aurora's brands include Aurora Drift, San Rafael '71, and MedReleaf among others.

Last updated: Oct 26, 2023